{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:46:22Z","timestamp":1790178382115,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Headache is the most common symptom of idiopathic intracranial hypertension (IIH) and may persist despite therapy, with a significant impact on quality of life. Since calcitonin gene-related peptide (CGRP) plays a crucial role in the pathophysiology and management of primary headaches such as migraine, this raises the question whether CGRP also contributes to headache in IIH. Therefore, we compared tear fluid CGRP levels between IIH patients with headache and healthy controls, and in IIH patients before and after CSF pressure normalization by therapeutic lumbar puncture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>IIH patients with headache attributed to IIH and healthy controls were included. To avoid confounding with chronic migraine, IIH patients with a chronic migraine phenotype were excluded. Tear fluid was collected from IIH patients and controls. In IIH patients, an additional measurement was performed approximately 3\u00a0h after therapeutic lumbar puncture. CGRP levels were analyzed using a commercially available ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-three IIH patients (all female; age: 34.0\u2009\u00b1\u20098.8 years) and 20 healthy controls (all female, age: 25.7\u2009\u00b1\u20095.5 years) were included. IIH patients had 16.4\u2009\u00b1\u200912.3 headache days per month and headache was mostly bilateral and pressing. Baseline tear fluid CGRP levels were significantly lower in IIH patients compared to healthy controls (2.4\u2009\u00b1\u20091.2 ng\/ml vs. 4.9\u2009\u00b1\u20094.2 ng\/ml,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). There was no significant change in CGRP levels in IIH patients before vs. after therapeutic lumbar puncture (2.4\u2009\u00b1\u20091.2 vs. 2.4\u2009\u00b1\u20091.7 ng\/ml,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.236). Similarly, in the subgroup with immediate headache improvement, CGRP levels remained unchanged (before: 2.2\u2009\u00b1\u20090.9 ng\/ml, after: 2.8\u2009\u00b1\u20092.4 ng\/ml;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.674).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Tear fluid CGRP levels were lower in IIH patients with headache but without a chronic migraine phenotype compared to healthy controls. In addition, CSF pressure normalization was not associated with changes in CGRP levels after 3\u00a0h. These results do not support a major role of CGRP in IIH-associated headache without a chronic migraine phenotype.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was previously registered at the German Clinical Trial Register (DRKS www.drks.de) (DRKS00025278), Trial registration date 25.06.2021.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10194-026-02453-5","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:09:25Z","timestamp":1784855365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tear fluid Calcitonin gene-related peptide in patients with idiopathic intracranial hypertension headache \u2013 a prospective case-control study"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4319-7734","authenticated-orcid":false,"given":"Cem","family":"Thunstedt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Shehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozan E.","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Straube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Ruscheweyh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"issue":"5","key":"2453_CR1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2017.01.006","volume":"124","author":"KP Kilgore","year":"2017","unstructured":"Kilgore KP, Lee MS, Leavitt JA et al (2017) Re-evaluating the incidence of idiopathic intracranial hypertension in an era of increasing obesity. Ophthalmology 124(5):697\u2013700","journal-title":"Ophthalmology"},{"issue":"3","key":"2453_CR2","doi-asserted-by":"publisher","first-page":"e208036","DOI":"10.1212\/WNL.0000000000208036","volume":"102","author":"JK Shaia","year":"2024","unstructured":"Shaia JK, Sharma N, Kumar M et al (2024) Changes in prevalence of idiopathic intracranial hypertension in the United States between 2015 and 2022, stratified by sex, race, and ethnicity. Neurology 102(3):e208036","journal-title":"Neurology"},{"issue":"12","key":"2453_CR3","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1111\/ene.12512","volume":"21","author":"HM Yri","year":"2014","unstructured":"Yri HM, R\u00f6nnb\u00e4ck C, Wegener M et al (2014) The course of headache in idiopathic intracranial hypertension: a 12-month prospective follow-up study. Eur J Neurol 21(12):1458\u20131464","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"2453_CR4","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1007\/s10072-013-1388-7","volume":"34","author":"D D\u2019Amico","year":"2013","unstructured":"D\u2019Amico D, Curone M, Ciasca P et al (2013) Headache prevalence and clinical features in patients with idiopathic intracranial hypertension (IIH). Neurol Sci 34(Suppl 1):S147\u2013S149","journal-title":"Neurol Sci"},{"issue":"9","key":"2453_CR5","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1016\/S0161-6420(98)99039-X","volume":"105","author":"MC Brodsky","year":"1998","unstructured":"Brodsky MC, Vaphiades M (1998) Magnetic resonance imaging in pseudotumor cerebri. Ophthalmology 105(9):1686\u20131693","journal-title":"Ophthalmology"},{"issue":"13","key":"2453_CR6","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1212\/WNL.0b013e3182a55f17","volume":"81","author":"DI Friedman","year":"2013","unstructured":"Friedman DI, Liu GT, Digre KB (2013) Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology 81(13):1159\u20131165","journal-title":"Neurology"},{"issue":"1","key":"2453_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s10194-018-0919-2","volume":"19","author":"J Hoffmann","year":"2018","unstructured":"Hoffmann J, Mollan SP, Paemeleire K et al (2018) European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain 19(1):93","journal-title":"J Headache Pain"},{"issue":"16","key":"2453_CR8","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1001\/jama.2014.3312","volume":"311","author":"M Wall","year":"2014","unstructured":"NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP et al (2014) Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA 311(16):1641\u20131651","journal-title":"JAMA"},{"issue":"24","key":"2453_CR9","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1212\/WNL.0000000000001687","volume":"84","author":"KB Digre","year":"2015","unstructured":"Digre KB, Bruce BB, McDermott MP et al (2015) Quality of life in idiopathic intracranial hypertension at diagnosis: IIH treatment trial results. Neurology 84(24):2449\u20132456","journal-title":"Neurology"},{"issue":"Suppl 1","key":"2453_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10072-015-2164-7","volume":"36","author":"R De Simone","year":"2015","unstructured":"De Simone R, Ranieri A (2015) The role of intracranial hypertension in the chronification of migraine. Neurol Sci 36(Suppl 1):23\u201328","journal-title":"Neurol Sci"},{"issue":"12","key":"2453_CR11","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1177\/0333102419856640","volume":"39","author":"K Kamm","year":"2019","unstructured":"Kamm K, Straube A, Ruscheweyh R (2019) Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls. Cephalalgia 39(12):1535\u20131543","journal-title":"Cephalalgia"},{"issue":"4","key":"2453_CR12","doi-asserted-by":"publisher","first-page":"333102423115936","DOI":"10.1177\/03331024231159366","volume":"43","author":"F Haghdoost","year":"2023","unstructured":"Haghdoost F, Puledda F, Garcia-Azorin D et al (2023) Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: a systematic review and network meta-analysis of phase 3 randomised controlled trials. Cephalalgia 43(4):3331024231159366","journal-title":"Cephalalgia"},{"issue":"1","key":"2453_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s10194-020-01182-7","volume":"21","author":"A Yiangou","year":"2020","unstructured":"Yiangou A, Mitchell JL, Vijay V et al (2020) Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension. J Headache Pain 21(1):116","journal-title":"J Headache Pain"},{"issue":"5","key":"2453_CR14","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/WNL.46.5.1226","volume":"46","author":"NT Mathew","year":"1996","unstructured":"Mathew NT, Ravishankar K, Sanin LC (1996) Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 46(5):1226\u20131230","journal-title":"Neurology"},{"key":"2453_CR15","doi-asserted-by":"publisher","first-page":"108136","DOI":"10.1016\/j.clineuro.2024.108136","volume":"237","author":"AK Ak","year":"2024","unstructured":"Ak AK, Gemici YI, Batum M et al (2024) Calcitonin gene-related peptide (CGRP) levels in peripheral blood in patients with idiopathic intracranial hypertension and migraine. Clin Neurol Neurosurg 237:108136","journal-title":"Clin Neurol Neurosurg"},{"issue":"1","key":"2453_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s10194-025-02042-y","volume":"26","author":"NS Hansen","year":"2025","unstructured":"Hansen NS, Korsbaek JJ, Bak LK et al (2025) Calcitonin gene-related peptide in newly diagnosed idiopathic intracranial hypertension: a prospective, cross-sectional, case-control study of cerebrospinal fluid and plasma. J Headache Pain 26(1):95","journal-title":"J Headache Pain"},{"issue":"1","key":"2453_CR17","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s10194-024-01799-y","volume":"25","author":"N Krajnc","year":"2024","unstructured":"Krajnc N, Frank F, Macher S et al (2024) Plasma calcitonin gene-related peptide levels in idiopathic intracranial hypertension: an exploratory study. J Headache Pain 25(1):92","journal-title":"J Headache Pain"},{"key":"2453_CR18","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38(1):1\u2013211","DOI":"10.1177\/0333102417738202"},{"issue":"1","key":"2453_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12955-018-0871-5","volume":"16","author":"T Benz","year":"2018","unstructured":"Benz T, Lehmann S, Gantenbein AR et al (2018) Translation, cross-cultural adaptation and reliability of the German version of the migraine disability assessment (MIDAS) questionnaire. Health Qual Life Outcomes 16(1):42","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"2453_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1023\/A:1026119331193","volume":"12","author":"M Kosinski","year":"2003","unstructured":"Kosinski M, Bayliss MS, Bjorner JB et al (2003) A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 12(8):963\u2013974","journal-title":"Qual Life Res"},{"issue":"1","key":"2453_CR21","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s11136-008-9418-2","volume":"18","author":"AJ Selim","year":"2009","unstructured":"Selim AJ, Rogers W, Fleishman JA et al (2009) Updated U.S. population standard for the Veterans RAND 12-item Health Survey (VR-12). Qual Life Res 18(1):43\u201352","journal-title":"Qual Life Res"},{"issue":"1","key":"2453_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s10194-025-02255-1","volume":"27","author":"K Kamm","year":"2025","unstructured":"Kamm K, Brandi-Dohrn A, Straube A et al (2025) Tear fluid calcitonin gene-related peptide (CGRP) is elevated during spontaneous migraine attacks: results from a pilot study. J Headache Pain 27(1):31","journal-title":"J Headache Pain"},{"issue":"1","key":"2453_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s10194-024-01769-4","volume":"25","author":"G G\u00e1rate","year":"2024","unstructured":"G\u00e1rate G, Pascual J, Pascual-Mato M et al (2024) Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience. J Headache Pain 25(1):69","journal-title":"J Headache Pain"},{"issue":"1","key":"2453_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.arcmed.2022.12.002","volume":"54","author":"G G\u00e1rate","year":"2023","unstructured":"G\u00e1rate G, Pascual M, Rivero M et al (2023) Serum Calcitonin Gene-Related Peptide \u03b1 and \u03b2 Levels are Increased in COVID-19 Inpatients. Arch Med Res 54(1):56\u201363","journal-title":"Arch Med Res"},{"issue":"10","key":"2453_CR25","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1111\/head.15011","volume":"65","author":"ML Garelja","year":"2025","unstructured":"Garelja ML, Rees TA, Hay DL (2025) Calcitonin gene-related peptide and headache: Comparison of two commonly used assay kits highlights the perils of measuring neuropeptides with enzyme-linked immunosorbent assays. Headache 65(10):1744\u20131753","journal-title":"Headache"},{"issue":"1","key":"2453_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/s10194-025-02141-w","volume":"26","author":"K Kamm","year":"2025","unstructured":"Kamm K, Khorsandian MC, Straube A et al (2025) Tear fluid CGRP rises during glyceryl trinitrate-induced headache in migraine patients. J Headache Pain 26(1):260","journal-title":"J Headache Pain"},{"issue":"4","key":"2453_CR27","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0196-9781(91)90147-H","volume":"12","author":"PM Zelissen","year":"1991","unstructured":"Zelissen PM, Koppeschaar HP, Lips CJ et al (1991) Calcitonin gene-related peptide in human obesity. Peptides 12(4):861\u2013863","journal-title":"Peptides"},{"issue":"14","key":"2453_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1212\/WNL.0b013e3182a6cb72","volume":"81","author":"E Cernuda-Moroll\u00f3n","year":"2013","unstructured":"Cernuda-Moroll\u00f3n E, Larrosa D, Ram\u00f3n C et al (2013) Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 81(14):1191\u20131196","journal-title":"Neurology"},{"issue":"2","key":"2453_CR29","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1601-0825.2010.01717.x","volume":"17","author":"MU Jang","year":"2011","unstructured":"Jang MU, Park JW, Kho HS et al (2011) Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis 17(2):187\u2013193","journal-title":"Oral Dis"},{"issue":"Suppl 1","key":"2453_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/head.13305","volume":"58","author":"L Edvinsson","year":"2018","unstructured":"Edvinsson L (2018) The CGRP pathway in migraine as a viable target for therapies. Headache 58(Suppl 1):33\u201347","journal-title":"Headache"},{"issue":"1","key":"2453_CR31","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410330109","volume":"33","author":"PJ Goadsby","year":"1993","unstructured":"Goadsby PJ, Edvinsson L (1993) The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 33(1):48\u201356","journal-title":"Ann Neurol"},{"issue":"1","key":"2453_CR32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s10194-017-0741-2","volume":"18","author":"WS Schou","year":"2017","unstructured":"Schou WS, Ashina S, Amin FM et al (2017) Calcitonin gene-related peptide and pain: a systematic review. J Headache Pain 18(1):34","journal-title":"J Headache Pain"},{"issue":"Pt 1","key":"2453_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/brain\/awn307","volume":"132","author":"HW Schytz","year":"2009","unstructured":"Schytz HW, Birk S, Wienecke T et al (2009) PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132(Pt 1):16\u201325","journal-title":"Brain"},{"issue":"6","key":"2453_CR34","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1365-2265.2008.03401.x","volume":"70","author":"AK Ball","year":"2009","unstructured":"Ball AK, Sinclair AJ, Curnow SJ et al (2009) Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance. Clin Endocrinol (Oxf) 70(6):863\u2013869","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2453_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s10194-024-01851-x","volume":"25","author":"S Zaic","year":"2024","unstructured":"Zaic S, Krajnc N, Macher S et al (2024) Therapeutic effect of a single lumbar puncture in idiopathic intracranial hypertension. J Headache Pain 25(1):145","journal-title":"J Headache Pain"},{"issue":"1","key":"2453_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/head.14026","volume":"61","author":"A Yiangou","year":"2021","unstructured":"Yiangou A, Mitchell JL, Fisher C et al (2021) Erenumab for headaches in idiopathic intracranial hypertension: a prospective open-label evaluation. Headache 61(1):157\u2013169","journal-title":"Headache"},{"key":"2453_CR37","doi-asserted-by":"publisher","first-page":"105597","DOI":"10.1016\/j.clineuro.2019.105597","volume":"188","author":"BR Wakerley","year":"2020","unstructured":"Wakerley BR, Warner R, Cole M et al (2020) Cerebrospinal fluid opening pressure: the effect of body mass index and body composition. Clin Neurol Neurosurg 188:105597","journal-title":"Clin Neurol Neurosurg"},{"issue":"10","key":"2453_CR38","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1212\/WNL.33.10.1386","volume":"33","author":"JJ Corbett","year":"1983","unstructured":"Corbett JJ, Mehta MP (1983) Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumor cerebri. Neurology 33(10):1386\u20131388","journal-title":"Neurology"},{"issue":"8","key":"2453_CR39","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/head.13153","volume":"57","author":"DI Friedman","year":"2017","unstructured":"Friedman DI, Quiros PA, Subramanian PS et al (2017) Headache in idiopathic intracranial hypertension: findings from the idiopathic intracranial hypertension treatment trial. Headache 57(8):1195\u20131205","journal-title":"Headache"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10194-026-02453-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-026-02453-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T01:09:26Z","timestamp":1784855366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10194-026-02453-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2453"],"URL":"https:\/\/doi.org\/10.1186\/s10194-026-02453-5","relation":{},"ISSN":["1129-2377"],"issn-type":[{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"25 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the medical faculty of the Ludwig-Maximilians-University Munich (No.\n                      21\u20130149\n                      )\n                      Contact\n                      : \u201cEthikkommission bei der Medizinischen Fakult\u00e4t der Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen\u201d; Pettenkoferstr. 8, 80336 Munich, Phone: +49 89 4400 55190; E-Mail: ethikkommission@med.uni-muenchen.de.","order":1,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients were giving written informed consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"189"}}